- Home
- IMNM vs PRLB Comparison
IMNM vs PRLB Comparison
Compare IMNM & PRLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- PRLB
- Stock Information
- Founded
- IMNM 2006
- PRLB 1999
- Country
- IMNM United States
- PRLB United States
- Employees
- IMNM N/A
- PRLB N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- PRLB Metal Fabrications
- Sector
- IMNM Health Care
- PRLB Industrials
- Exchange
- IMNM Nasdaq
- PRLB Nasdaq
- Market Cap
- IMNM 747.7M
- PRLB 713.9M
- IPO Year
- IMNM 2020
- PRLB 2012
- Fundamental
- Price
- IMNM $9.91
- PRLB $37.49
- Analyst Decision
- IMNM Strong Buy
- PRLB Buy
- Analyst Count
- IMNM 5
- PRLB 4
- Target Price
- IMNM $28.60
- PRLB $40.33
- AVG Volume (30 Days)
- IMNM 695.8K
- PRLB 341.7K
- Earning Date
- IMNM 11-13-2024
- PRLB 11-01-2024
- Dividend Yield
- IMNM N/A
- PRLB N/A
- EPS Growth
- IMNM N/A
- PRLB N/A
- EPS
- IMNM N/A
- PRLB 0.94
- Revenue
- IMNM $10,129,000.00
- PRLB $504,188,000.00
- Revenue This Year
- IMNM N/A
- PRLB $0.88
- Revenue Next Year
- IMNM N/A
- PRLB $3.03
- P/E Ratio
- IMNM N/A
- PRLB $39.76
- Revenue Growth
- IMNM N/A
- PRLB 1.97
- 52 Week Low
- IMNM $6.93
- PRLB $25.76
- 52 Week High
- IMNM $30.96
- PRLB $41.87
- Technical
- Relative Strength Index (RSI)
- IMNM 30.69
- PRLB 62.33
- Support Level
- IMNM $12.46
- PRLB $27.18
- Resistance Level
- IMNM $13.52
- PRLB $40.00
- Average True Range (ATR)
- IMNM 0.85
- PRLB 1.93
- MACD
- IMNM -0.15
- PRLB 0.47
- Stochastic Oscillator
- IMNM 6.71
- PRLB 80.65
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.
About PRLB Proto Labs Inc. Common stock
Proto Labs Inc is an on-demand manufacturer of custom parts for prototyping and short-run production. The company offers developers and engineers quick-turn production services to reduce the time to market. Proto Labs uses injection molding, computer numerical control machining, and 3-D printing to manufacture custom parts for its clients. The company services clients' needs for prototype solutions, parts for testing procedures, bridge production capabilities during disruptions in manufacturing processes, limited-quantity requests, and end-of-life production support. The majority of its revenue is derived from the United States of America.